Development and Validation of Chlamydia muridarum Mouse Models for Studying Genital Tract Infection Pathogenesis

Yihui Wang1,2, Zixuan Han3, Luying Wang4

  • 1Department of Biomedical Engineering, Pratt School of Engineering, Duke University, Durham, NC, USA.

Bio-Protocol
|February 17, 2025
PubMed

Insights

This study presents a mouse model for Chlamydia muridarum infection, enabling visualization of genital tract pathologies. This model aids in understanding bacterial infections and developing new treatments.

Area of Science:

  • Microbiology
  • Immunology
  • Pathogenesis

Background:

  • * *Chlamydia trachomatis* causes infections in mucosal tissues, leading to severe chronic conditions like infertility.
  • * Animal models are crucial for studying bacterial pathogenesis, host-pathogen interactions, and evaluating treatments.
  • * Current models have limitations in mimicking natural infection routes and visualizing specific tissue responses.

Purpose of the Study:

  • * To develop and present a refined mouse model for visualizing *Chlamydia muridarum* pathologies in the endometrium and oviduct.
  • * To establish a protocol for studying genital tract infections and host responses.
  • * To facilitate research on *Chlamydia* pathogenesis and therapeutic interventions.

Main Methods:

  • * Utilized a mouse-adapted *Chlamydia muridarum* strain for inoculation.
  • * Employed both intravaginal and transcervical inoculation techniques.
  • * Incorporated specialized equipment for precise inoculation and visualization of pathologies.

Main Results:

  • * Successfully visualized endometrial and oviduct pathologies following *C. muridarum* inoculation.
  • * The developed model allows for direct observation of infection progression in key reproductive tissues.
  • * Demonstrated the utility of the model for studying host-pathogen dynamics.

Conclusions:

  • * The mouse-adapted *Chlamydia muridarum* model provides a valuable tool for studying genital tract infections.
  • * This model enhances the understanding of chlamydial pathogenesis and associated pathologies.
  • * It serves as a platform for evaluating the efficacy of novel antimicrobial strategies.